Cargando…
Cellular Responses to Proteasome Inhibition: Molecular Mechanisms and Beyond
Proteasome inhibitors have been actively tested as potential anticancer drugs and in the treatment of inflammatory and autoimmune diseases. Unfortunately, cells adapt to survive in the presence of proteasome inhibitors activating a variety of cell responses that explain why these therapies have not...
Autores principales: | Albornoz, Nicolas, Bustamante, Hianara, Soza, Andrea, Burgos, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678303/ https://www.ncbi.nlm.nih.gov/pubmed/31295808 http://dx.doi.org/10.3390/ijms20143379 |
Ejemplares similares
-
Interplay Between the Autophagy-Lysosomal Pathway and the Ubiquitin-Proteasome System: A Target for Therapeutic Development in Alzheimer’s Disease
por: Bustamante, Hianara A., et al.
Publicado: (2018) -
The Proteasomal Deubiquitinating Enzyme PSMD14 Regulates Macroautophagy by Controlling Golgi-to-ER Retrograde Transport
por: Bustamante, Hianara A, et al.
Publicado: (2020) -
Adaptation of Proteasomes and Lysosomes to Cellular Environments
por: Mebratu, Yohannes Afework, et al.
Publicado: (2020) -
The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement
por: Bachiller, Sara, et al.
Publicado: (2020) -
The Molecular Mechanisms Governing the Assembly of the Immuno- and Thymoproteasomes in the Presence of Constitutive Proteasomes
por: Watanabe, Ayaka, et al.
Publicado: (2022)